https://pmc.ncbi.nlm.nih.gov/articles/PMC10675414/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12018234/
https://pubmed.ncbi.nlm.nih.gov/20834180/ I smell P-hacking.
Note that none of these address neural regeneration (after concussions, as claimed by oneshtein) because I'll leave that for the supporters to demonstrate.
You posted links earlier, which suffices.
While there may be some conspiracy stuff there, "big medicine" saying you need to pay $20k/yr out of pocket for something will definitely lead people to find alternatives.
Doesn't that disprove the conspiracy theory of Big Pharma keeping "natural treatments" from being developed?
Natural treatments don't get developed when they aren't effective.
> The US Patent Trial and Appeal Board, an administrative law body of the national patent office, denied patent US9066920B2 on January 3, siding with petitioner Insys, a rival biotech firm.
> The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”. More particularly, to the use of one or a combination of cannabinoids, CBD oil, in the treatment of generalized or partial seizures.
Good luck with enforcement.